The current proposal is focused on evaluating an intervention with potential to have a positive impact on the quality of life of individuals receiving chemotherapy with taxanes. The FACT-Taxane scale is a psychometric tool specifically developed to assess the impact of taxane based treatment (Cella, Peterman et al. 2003). However, quality of life is a composite measure, and requires a larger sample size to determine efficacy, and therefore it will only serve as a secondary endpoint.